SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 91 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 2.10 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $51,000 | -26.1% | 29,511 | -4.3% | 0.00% | -25.0% |
| Q2 2015 | $69,000 | +4.5% | 30,842 | -9.4% | 0.00% | 0.0% |
| Q1 2015 | $66,000 | +1.5% | 34,052 | +39.4% | 0.00% | 0.0% |
| Q4 2014 | $65,000 | -33.7% | 24,422 | -25.0% | 0.00% | -42.9% |
| Q3 2014 | $98,000 | -25.8% | 32,567 | +1.3% | 0.01% | -22.2% |
| Q2 2014 | $132,000 | -3.6% | 32,164 | +1.5% | 0.01% | -10.0% |
| Q1 2014 | $137,000 | -13.8% | 31,701 | +4.2% | 0.01% | -9.1% |
| Q4 2013 | $159,000 | – | 30,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,696,894 | $7,637,000 | 32.03% |
| Anson Funds Management LP | 989,204 | $348,000 | 0.11% |
| CAXTON CORP | 62,000 | $22,000 | 0.09% |
| McQueen, Ball & Associates Inc. | 102,742 | $36,000 | 0.03% |
| Sheaff Brock Investment Advisors, LLC | 320,000 | $113,000 | 0.01% |
| Roundview Capital LLC | 21,100 | $7,000 | 0.00% |
| QCM Cayman, Ltd. | 11,197 | $4,000 | 0.00% |
| ZACKS INVESTMENT MANAGEMENT | 193,406 | $68,000 | 0.00% |
| Renaissance Technologies | 2,504,200 | $881,000 | 0.00% |
| Squarepoint Ops LLC | 56,800 | $20,000 | 0.00% |